| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |